Chapter 228: Introduction to Parasitic Infections¶
Chapter 228 | Part 5: Infectious Diseases
KEY CLINICAL POINTS¶
- Parasitic infections are classified into helminths (worms) and protozoa, with distinct pathogenic mechanisms and treatment approaches.
- TMP-SMX is the most effective prophylaxis for Pneumocystis jirovecii pneumonia (PCP), particularly in immunocompromised patients.
- Helminthic infections (e.g., schistosomiasis, filariasis) and protozoal infections (e.g., malaria, leishmaniasis) require tailored diagnostic and therapeutic strategies.
- Travel history, geographic distribution, and immune status are critical for accurate diagnosis and differential diagnosis.
- Key diagnostic tools include microscopy, serology, imaging, and molecular methods, with treatment guided by parasite type and host factors.
1. DEFINITION & OVERVIEW¶
Parasitic infections are caused by helminths (worms) and protozoa. Helminths are multicellular organisms, while protozoa are unicellular. These infections are classified by their life cycle, transmission routes, and host interactions. Protozoa can multiply within host cells, while helminths require intermediate hosts for development.
1.1 Classification of Parasites¶
Parasites are divided into helminths (worms) and protozoa. Helminths include flatworms (flukes, tapeworms) and roundworms (nematodes). Protozoa are single-celled organisms with complex life cycles. Helminths often require intermediate hosts, while protozoa may complete their life cycle within the host.
1.2 Diagnostic Challenges¶
Diagnosis is complicated by the similarity between parasitic and bacterial/viral pathogens. Specialized techniques (e.g., PCR, antigen detection) are often required. Immune status and travel history are critical for differential diagnosis.
2. EPIDEMIOLOGY¶
Parasitic infections are prevalent in resource-poor regions, particularly where sanitation is inadequate. Risk factors include immunocompromise (e.g., HIV/AIDS), travel to endemic areas, and exposure to contaminated water or food. Global distribution varies by parasite type (e.g., malaria in tropical regions, leishmaniasis in the Mediterranean).
2.1 Geographic Distribution¶
Helminthic infections (e.g., schistosomiasis, filariasis) are common in tropical and subtropical regions. Protozoal infections (e.g., malaria, leishmaniasis) are prevalent in areas with poor sanitation and limited healthcare access.
2.2 Demographics¶
Children, travelers, and immunocompromised individuals (e.g., HIV patients) are at highest risk. Malaria disproportionately affects sub-Saharan Africa, while leishmaniasis is endemic in the Mediterranean and South America.
3. ETIOLOGY & PATHOPHYSIOLOGY¶
Helminths and protozoa have distinct life cycles. Helminths require intermediate hosts for development, while protozoa often complete their life cycle within the host. Pathogenesis involves tissue invasion, immune evasion, and organ damage. Protozoa may evade immune responses through antigenic variation or intracellular survival.
3.1 Helminth Life Cycles¶
Helminths (e.g., tapeworms, flukes) require intermediate hosts for larval development. Infections occur via ingestion of contaminated food/water or skin penetration. Larvae migrate through tissues, causing inflammation and granuloma formation.
3.2 Protozoan Pathogenesis¶
Protozoa (e.g., Plasmodium, Leishmania) replicate within host cells, evading immune detection. Malaria parasites (Plasmodium spp.) multiply in erythrocytes, causing hemolysis and systemic inflammation. Leishmania species replicate in macrophages, leading to granuloma formation.
4. CLINICAL FEATURES¶
Symptoms vary by parasite type. Common presentations include fever, diarrhea, abdominal pain, skin lesions, and neurological symptoms. Severe infections may cause organ failure, anemia, or neurological complications (e.g., cerebral malaria, leishmaniasis).
4.1 Helminthic Infections¶
Intestinal roundworms (e.g., Ascaris, hookworms) cause malnutrition and anemia. Flukes (e.g., Schistosoma) lead to liver or lung damage. Strongyloides can cause disseminated infection in immunocompromised hosts.
4.2 Protozoal Infections¶
Malaria presents with fever, chills, and anemia. Leishmaniasis causes skin ulcers, mucosal damage, or visceral involvement. Giardia and Cryptosporidium cause watery diarrhea in immunocompromised patients.
5. DIFFERENTIAL DIAGNOSIS¶
Differential diagnoses include bacterial infections (e.g., Salmonella, Shigella), viral infections (e.g., dengue, Zika), and other parasitic infections (e.g., toxoplasmosis, trypanosomiasis). Travel history, immune status, and geographic exposure are critical for accurate diagnosis.
6. INVESTIGATIONS & DIAGNOSIS¶
Diagnostic methods include microscopy (stool, blood, CSF), serology (antibody detection), molecular techniques (PCR), and imaging (CT, ultrasound). Specific tests for parasites include Giardia antigen detection, malaria microscopy, and Leishmania PCR.
6.1 Laboratory Tests¶
Stool exams for ova/cysts, blood smears for malaria parasites, and serology for Leishmania or Toxoplasma. PCR is used for rapid detection of protozoa and helminths.
6.2 Imaging¶
CT or ultrasound for hepatic cysts (echinococcosis), MRI for CNS involvement (cerebral malaria, toxoplasmosis), and X-ray for pulmonary nodules (Paragonimus).
7. MANAGEMENT & TREATMENT¶
Treatment varies by parasite type. Antiparasitic drugs (e.g., albendazole, mefloquine, primaquine) are used for helminths and protozoa. Prophylaxis with TMP-SMX is critical for immunocompromised patients. Supportive care includes hydration, antipyretics, and management of complications.
7.1 Antiparasitic Drugs¶
Albendazole for helminths, metronidazole for Giardia, and artemisinin derivatives for malaria. Primaquine is used for P. vivax and P. ovale to prevent relapse.
7.2 Prophylaxis¶
TMP-SMX for PCP prevention in HIV patients. Dapsone for Pneumocystis prophylaxis in patients with hypersensitivity to TMP-SMX.
8. PROGNOSIS & COMPLICATIONS¶
Prognosis depends on parasite type, immune status, and treatment adherence. Complications include organ failure, anemia, malnutrition, and neurological sequelae. Severe malaria or visceral leishmaniasis can be fatal without prompt treatment.
8.1 Immune Status¶
Immunocompromised patients (e.g., HIV, organ transplant recipients) are at higher risk for severe disease and disseminated infections. Prompt treatment is critical to prevent mortality.
8.2 Long-Term Effects¶
Chronic helminthic infections may lead to malnutrition, anemia, and organ damage. Protozoal infections (e.g., malaria) can cause long-term neurological or hepatic complications.
9. SPECIAL CONSIDERATIONS¶
Pregnancy, pediatrics, and elderly patients require tailored approaches. For example, certain antiparasitics (e.g., mefloquine) are contraindicated in pregnancy. Travelers should receive chemoprophylaxis for malaria and other endemic infections.
9.1 Pregnancy¶
Avoid drugs like mefloquine and chloroquine in the first trimester. Use safe alternatives (e.g., atovaquone-proguanil) for malaria prophylaxis.
9.2 Pediatrics¶
Children are at risk for severe infections (e.g., cerebral malaria, visceral leishmaniasis). Treatment must consider weight-based dosing and potential for drug toxicity.
10. KEY POINTS & CLINICAL PEARLS¶
- TMP-SMX is the gold standard for PCP prophylaxis in immunocompromised patients. 2. Travel history and geographic exposure are essential for diagnosis. 3. Helminthic infections often require long-term treatment due to repeated reinfections. 4. Protozoal infections (e.g., malaria) require prompt treatment to prevent mortality. 5. Immune status significantly influences disease severity and treatment outcomes.
Table 228-1: Parasitic Infections by Organ System and Signs/Symptoms¶
| ORGAN SYSTEM, MAJOR SIGN(S)/SYMPTOM(S) | PARASITE(S) | GEOGRAPHIC DISTRIBUTION | COMMENTS |
|---|---|---|---|
| Skin | Hookworm | Worldwide | Can cause anemia in heavy infections |
| Skin | Strongyloides | Moist tropics and subtropics | Disseminated infection in immunocompromise |
| Skin | Toxocara (animal roundworm) | Tropical and temperate zones | Cutaneous or visceral larva migrans |
| Skin | Onchocerca | Mexico, Central/South America, Africa | Painless ulcers; may cause destructive mucocutaneous infection |
| Skin | Loa loa (African eye worm) | Western and central Africa | Migratory nodules |
| Skin | Gnathostoma | Southeast Asia and China | Migratory nodules with eosinophilia |
| Skin | Dracunculus (Guinea worm) | Africa | Painful nodules, especially involving feet |
| Central Nervous System | Plasmodium falciparum | Subtropics and tropics | Cerebral malaria, especially in children |
| Central Nervous System | Trypanosoma brucei rhodesiense | Sub-Saharan eastern Africa | Painful chancre from tsetse fly bite; death in weeks to months |
| Central Nervous System | Acanthamoeba | Worldwide | Immunocompromised individuals |
| Central Nervous System | Balamuthia | Americas | Indolent meningoencephalitis with brain mass |
| Central Nervous System | Toxoplasma | Worldwide | Reactivation disease in immunocompromise; ring-enhancing lesions |
| Central Nervous System | Taenia solium | Mexico, Central/South America, Africa | Cysticercosis; variable sized or calcified larval cysts on CT |
| ORGAN SYSTEM, MAJOR SIGN(S)/SYMPTOM(S) | PARASITE(S) | GEOGRAPHIC DISTRIBUTION | COMMENTS |
|---|---|---|---|
| Central Nervous System | Schistosoma japonicum | Far East | Aberrant eggs can form brain or spinal cord masses |
| Central Nervous System | Schistosoma mansoni | Africa, Central/South America | Aberrant eggs can form brain or spinal cord masses |
| Eyes | Acanthamoeba | Worldwide | Freshwater and brackish water; corneal trauma |
| Eyes | Onchocerca | Mexico, Central/South America, Africa | Immune response to microfilaria in cornea |
| Eyes | Toxoplasma | Worldwide | Congenital or adult visual loss; reactivation in immunocompromised |
| Eyes | Toxocara | Worldwide | Retinal mass (ocular larva migrans) |
| Eyes | Onchocerca | Mexico, Central/South America, Africa | Visible roundworm in eye |
| Eyes | L. loa | Western and central Africa | Worms may cross eye during migration |
| Eyes | Gnathostoma | Southeast Asia and China | Pain, possible vision loss |
| Lungs | Paragonimus | Far East, Africa, Americas | Pulmonary nodule/abscess; ectopic migration to abdomen or CNS |
| Lungs | Migrating helminths | Worldwide | Loeffler’s syndrome from migrating Ascaris, hookworm, Strongyloides |
| Heart | P. falciparum (complication) | Tropics and subtropics | Pulmonary edema from severe malaria |
| Heart | Trypanosoma cruzi | Mexico, Central/South America | Cardiomegaly, arrhythmias; AIDS-defining infection |
| Gastrointestinal Tract | Malaria (multiple episodes) | Tropics and subtropics | Hepatosplenomegaly with anemia and recurrent fever |
| Gastrointestinal Tract | S. mansoni | Africa, Central/South America | Portal obstruction with cirrhosis and late varices |
| Gastrointestinal Tract | Leishmania donovani complex | Tropics and subtropics | Visceral leishmaniasis; AIDS-defining infection |
| Gastrointestinal Tract | Entamoeba histolytica | Tropics | Hepatomegaly; acute with fever, right-upper-quadrant pain |
| Gastrointestinal Tract | Echinococcus | Sheep-raising areas | Characteristic liver cysts > lung |
| Gastrointestinal Tract | Fasciola | Sheep-raising areas | Eosinophilia |
| Gastrointestinal Tract | Clonorchis | China, Southeast Asia | Cholangitis; late cholangiocarcinoma |
| ORGAN SYSTEM, MAJOR SIGN(S)/SYMPTOM(S) | PARASITE(S) | GEOGRAPHIC DISTRIBUTION | COMMENTS |
|---|---|---|---|
| Gastrointestinal Tract | Microsporidia | Worldwide | AIDS-related chronic diarrhea |
| Gastrointestinal Tract | Cryptosporidium | Worldwide | AIDS-defining infection; severe in immunocompromised |
| Gastrointestinal Tract | E. histolytica | Tropics | Bloody diarrhea; less fever than bacterial etiology |
| Gastrointestinal Tract | S. mansoni | Africa, Central/South America | Only in heavy, acute infection with fever and eosinophilia |
| Gastrointestinal Tract | S. japonicum | Far East | Only in heavy, acute infection |
| Gastrointestinal Tract | Cryptosporidium | Worldwide | Watery diarrhea; severe in immunocompromised |
| Gastrointestinal Tract | Giardia | Worldwide | Foul-smelling stool with steatorrhea |
| Gastrointestinal Tract | Isospora belli | Worldwide | Fever, abdominal pain, chronic diarrhea |
| Gastrointestinal Tract | Capillaria | Southeast Asia, Egypt | Malabsorption, wasting |
| Gastrointestinal Tract | Ascaris | Worldwide | Passage of large roundworm (>6 cm) |
| Gastrointestinal Tract | Pinworm | Worldwide | Small roundworms visible around anus; anal itching |
| Gastrointestinal Tract | Trichuris | Worldwide | Rectal prolapse with heavy infection in children |
| Gastrointestinal Tract | T. solium or Taenia saginata | Worldwide | Passage of tapeworm segments |
| Gastrointestinal Tract | Diphyllobothrium latum | Worldwide | Pernicious anemia in genetically predisposed Scandinavians |
| Genitourinary System | Trichomonas vaginalis | Worldwide | Itchy discharge; common sexually transmitted disease |
| Genitourinary System | Schistosoma haematobium | Africa | Hematuria with negative cultures; late bladder cancer |